Position in VERA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,178,969
-$360,144 QoQ
Shares Held
50,780
-19.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 217 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. VERA ranks #147 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,178,969 | 50,780 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,539,113 | 63,115 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $3,246,377 | 64,107 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,393,525 | 82,365 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $7,316,485 | 310,547 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,146,761 | 47,742 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,366,599 | 221,485 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,705,997 | 129,095 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $4,839,942 | 133,774 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $14,469,517 | 335,564 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $482,084 | 31,345 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $316,166 | 23,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $421,006 | 26,231 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $129,141 | 16,642 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,204,024 | 113,982 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,605,281 | 75,330 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,346,517 | 98,936 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,514,127 | 149,601 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,034,086 | 76,126 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,364,612 | 78,652 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||